LONGEVA.

Glutathione: adverse events and evidence limits

A crossover study in eight patients with mild asthma observed airway narrowing, cough and breathlessness after nebulized glutathione. [1]

This short inhalation-challenge observation does not establish oral or injectable-formulation risks. [1]

What the studies reported

EffectModel or participantsHow often or as describedSource
Airway narrowing (bronchoconstriction)Eight patients with mild asthma, nebulized glutathione, crossover studyObserved after a short inhalation challenge; no frequency given; the observation does not establish oral or injectable-formulation risks[1]
CoughThe same patientsObserved after the inhalation challenge; no frequency given[1]
BreathlessnessThe same patientsObserved after the inhalation challenge; no frequency given[1]

References

  1. R M Marrades et al. (1997). Nebulized glutathione induces bronchoconstriction in patients with mild asthma https://doi.org/10.1164/ajrccm.156.2.9611001.